Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13 GBX | 0.00% |
|
+4.00% | +23.81% |
Jun. 21 | BiVictriX Therapeutics Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jun. 13 | EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss | AN |
Business Summary
Number of employees: 17
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tiffany Thorn
FOU | Founder | 37 | 15-12-31 |
Adrian Howd
DFI | Director of Finance/CFO | 52 | 23-10-02 |
Oliver Schon
PRN | Corporate Officer/Principal | - | 21-09-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kauffman
CHM | Chairman | 60 | 22-01-15 |
William Paris
BRD | Director/Board Member | 73 | 21-09-21 |
Susan Lowther
BRD | Director/Board Member | 65 | 21-09-21 |
Tiffany Thorn
FOU | Founder | 37 | 15-12-31 |
Robert Hawkins
BRD | Director/Board Member | 69 | 21-09-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,526,088 | 51,083,823 ( 61.90 %) | 0 | 61.90 % |
Company contact information
BiVictriX Therapeutics Plc
Mereside Alderley Park Alderley Edge
SK10 4TG, Macclesfield
+
http://www.bivictrix.com![address BiVictriX Therapeutics plc(BVX)](https://cdn.zonebourse.com/static/address/125758628.png)
Sector
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.81% | 13.71M | |
+16.71% | 44.48B | |
+43.74% | 40.57B | |
-7.92% | 38.82B | |
+33.09% | 32.22B | |
-7.10% | 27.84B | |
+14.46% | 26.79B | |
+46.73% | 14.31B | |
+34.07% | 12.7B | |
-7.61% | 11.23B |
- Stock Market
- Equities
- BVX Stock
- Company BiVictriX Therapeutics plc